Hemofiltration in sepsis: where do we go from here?
Open Access
- 1 January 2000
- journal article
- Published by Springer Nature in Critical Care
- Vol. 4 (2) , 69-71
- https://doi.org/10.1186/cc659
Abstract
Hemofiltration as an adjunct to therapy for sepsis is now 10 years old. Despite early successes and significant theoretical advantages, the treatment remains experimental. Although feasibility has been established, efficacy has proved to be much more difficult. Clinical as well as technical difficulties remain important considerations to future studies. These issues are discussed and the brief history of hemofiltration in sepsis is reviewed.Keywords
This publication has 17 references indexed in Scilit:
- Continuous plasmafiltration in sepsis syndromeCritical Care Medicine, 1999
- Diffusive vs. convective therapyCritical Care Medicine, 1998
- Expression of Adhesion Molecules and Activation Markers on Lymphocytes and Monocytes during HemodialysisBlood Purification, 1997
- Management of acute renal failure: New perspectivesAmerican Journal of Kidney Diseases, 1996
- Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinNew England Journal of Medicine, 1996
- Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigsJournal of Critical Care, 1993
- Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swineCritical Care Medicine, 1993
- Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patientsCritical Care Medicine, 1993
- High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pigIntensive Care Medicine, 1992
- Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shockIntensive Care Medicine, 1990